UniSa - IRIS Institutional Research Information System

ERRO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.839
NA - Nord America 7.158
EU - Europa 2.808
SA - Sud America 1.751
AF - Africa 122
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.750
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 11.376
US - Stati Uniti d'America 6.986
SG - Singapore 2.008
BR - Brasile 1.434
CN - Cina 837
VN - Vietnam 753
IT - Italia 725
RU - Federazione Russa 516
UA - Ucraina 365
IE - Irlanda 309
TR - Turchia 289
DE - Germania 250
KR - Corea 226
SE - Svezia 192
AR - Argentina 133
GB - Regno Unito 113
CA - Canada 87
FI - Finlandia 76
IN - India 75
ID - Indonesia 73
EC - Ecuador 57
MX - Messico 49
PL - Polonia 47
BD - Bangladesh 44
CO - Colombia 38
NL - Olanda 38
EE - Estonia 37
AU - Australia 36
ZA - Sudafrica 36
JP - Giappone 35
NZ - Nuova Zelanda 28
AT - Austria 27
IQ - Iraq 27
ES - Italia 26
PY - Paraguay 24
VE - Venezuela 19
MA - Marocco 18
CZ - Repubblica Ceca 16
UY - Uruguay 15
CL - Cile 13
UZ - Uzbekistan 13
EG - Egitto 12
FR - Francia 12
PE - Perù 12
DZ - Algeria 11
LT - Lituania 10
DO - Repubblica Dominicana 9
KE - Kenya 9
PK - Pakistan 9
NP - Nepal 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
IL - Israele 7
IR - Iran 7
JO - Giordania 7
BE - Belgio 6
BO - Bolivia 6
JM - Giamaica 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
GR - Grecia 5
KW - Kuwait 5
MD - Moldavia 5
PA - Panama 5
ET - Etiopia 4
BG - Bulgaria 3
BH - Bahrain 3
CR - Costa Rica 3
HU - Ungheria 3
LB - Libano 3
NO - Norvegia 3
RS - Serbia 3
SO - Somalia 3
TH - Thailandia 3
CY - Cipro 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
ME - Montenegro 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
OM - Oman 2
RW - Ruanda 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
Totale 27.719
Salva come PNG Salva come JPEG
Città #
Hong Kong 11.369
Ann Arbor 1.219
Singapore 911
Princeton 848
Dallas 657
Chandler 538
Wilmington 494
Jacksonville 427
Ashburn 367
Dublin 301
Izmir 265
Ho Chi Minh City 244
Woodbridge 216
Houston 196
Salerno 186
Beijing 168
Dong Ket 162
Moscow 153
Andover 127
Hanoi 123
Pellezzano 121
São Paulo 120
Nanjing 115
Naples 98
Los Angeles 89
The Dalles 88
Boardman 69
Norwalk 69
Fairfield 62
Munich 53
New York 52
Rio de Janeiro 46
Düsseldorf 44
Nuremberg 44
Shenyang 43
Brasília 40
Warsaw 39
Tallinn 37
Hebei 36
Nanchang 34
Pune 34
Changsha 30
Curitiba 30
Tokyo 30
Dearborn 29
Haiphong 29
Belo Horizonte 28
Council Bluffs 28
Seoul 28
Columbus 27
Mestre 27
West Jordan 27
Jiaxing 26
Montreal 26
Boston 25
Rome 25
Johannesburg 24
Stockholm 24
Brooklyn 23
Orem 23
San Diego 23
Da Nang 22
Fortaleza 22
London 22
Redwood City 22
Santa Clara 22
Seattle 22
Guarulhos 21
Porto Alegre 21
Turku 20
Guayaquil 19
Uberlândia 19
Quito 17
Salvador 17
San Francisco 17
Washington 17
Amsterdam 16
Chicago 16
Cambridge 15
Denver 15
Sydney 15
Toronto 15
Atlanta 14
Lecce 14
Poplar 14
Thái Bình 14
Tianjin 14
Auckland 13
Goiânia 13
Guangzhou 13
Joinville 13
Milan 13
Phoenix 13
Piracicaba 13
Baghdad 12
Campinas 12
Falls Church 12
Ribeirão Preto 12
Tashkent 12
Ankara 11
Totale 21.460
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.172
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 932
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 918
Sex Differences in Parkinson’s Disease: From Bench to Bedside 631
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 524
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 517
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 497
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 483
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 443
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 440
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 433
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 432
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 376
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 368
Non-invasive brain stimulation for dystonia: therapeutic implications 343
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 340
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 313
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. 313
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 298
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 293
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 267
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 249
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 232
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 217
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 204
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 202
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 192
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 189
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 180
ADCY5 mutations are another cause of benign hereditary chorea 167
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 162
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 159
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 142
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 141
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 140
Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (Conversion Disorder): A pilot, single-blinded, randomized study 138
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 135
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 135
Increased bilirubin levels in de novo Parkinson's disease 131
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 128
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 127
The Motor Syndrome of Parkinson's Disease 125
Quitting smoking: An early non-motor feature of Parkinson's disease? 123
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 123
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 123
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 121
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 121
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 120
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 117
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 116
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 115
Abnormal eating behaviors in progressive supranuclear palsy. 114
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 114
Machine learning can predict mild cognitive impairment in Parkinson's disease 113
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 113
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 112
Cerebellar and brainstem functional abnormalities in patients with primary orthostatic tremor 112
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 109
Malabsorption is uncommon in restless legs syndrome. 106
Gender and non motor fluctuations in Parkinson's disease: A prospective study 105
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 102
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 100
On the relationship between side of onset and cognition in Parkinson disease 100
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 100
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 100
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 98
Early MRI findings in acquired hepatocerebral degeneration. 97
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 96
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 95
Impact of COVID-19 on neurological patients attending a botulinum toxin service 95
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 94
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 93
Orthostatic myoclonus associated with Caspr2 antibodies 93
A novel therapeutic approach for synucleinopathies 93
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 91
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 91
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 90
Non-motor correlates of smoking habits in de novo Parkinson's disease 90
Uric acid relates to dopamine transporter availability in Parkinson's disease. 88
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 88
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 87
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 87
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 87
Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for? 87
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 87
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 86
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 86
“Atypical” atypical parkinsonism: Critical appraisal of a cohort 86
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 86
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 83
Essential tremor plus rest tremor: current concepts and controversies 82
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 82
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 82
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 81
The "eye of the tiger" sign in pure akinesia with gait freezing. 78
Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study. 78
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 78
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies 78
Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials 77
Restless legs syndrome is a common feature of adult celiac disease 77
Totale 19.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021487 0 0 0 0 0 60 70 6 58 2 81 210
2021/20221.275 5 1 5 9 24 8 17 37 146 164 216 643
2022/20231.556 242 102 73 141 171 371 18 129 202 8 66 33
2023/20241.005 45 132 57 61 46 120 37 77 49 66 55 260
2024/20252.997 84 40 50 121 116 342 372 261 452 422 371 366
2025/202616.618 3.066 5.569 4.716 1.548 1.286 433 0 0 0 0 0 0
Totale 28.348